Zhongguo Fei Ai Za Zhi. 2019 Dec 20;22(12):798-804. doi: 10.3779/j.issn.1009-3419.2019.12.11.
[Lung Adenocarcinomas with Pulmonary Miliary Metastases: A Case Report and Literature Review].
Zhongguo fei ai za zhi = Chinese journal of lung cancer
[Article in Chinese]
Linxue Li, Liang Zhou, Jianyong Zhang
Affiliations
Affiliations
- The Second Department of Pulmonary and Critical Care Medicine, Affliated Hospital of Zunyi Medical University, Zunyi 563000, China.
PMID: 31874677
PMCID: PMC6935038 DOI: 10.3779/j.issn.1009-3419.2019.12.11
Abstract
BACKGROUND: Lung adenocarcinoma with miliary metastasis in both lungs is easily misdiagnosed. The aim of this study is to investigate the clinical features of lung adenocarcinoma with miliary metastases in both lungs and to improve the clinician's understanding of the disease.
METHODS: The clinical manifestation, radiology and pathology were analyzed in one patient with miliary intrapulmonary carcinomatosis in Affiliated Hospital of Zunyi Medical University. A review of literature was performed with "miliary intrapulmonary carcinomatosis", "lung cancer miliary", "pulmonary nodule, lung cancer" and "EGFR miliary" as key words in PubMed, Wangfang datebase and CNKI.
RESULTS: The patient was a 52 year-old woman with a history of productive cough for 2 months, which aggraveted with shortness of breath for 1 month. Her computed tomography of chest showed diffuse military nodules distributed at bilateral lungs. Computed tomography (CT)-guided needle biopsy of the left lung revealed lung adenocarcinoma and epidermal growth factor receptor (EGFR) exon 21 L858R mutation. The patient was treated with gefitinib 250 mg per day. The chest CT was reviewed several times during this period, which shows the double lung nodules were reduced. The patient is generally in good condition and her symptoms have improved. By literature review, we found relevant 7 Chinese articles and 56 English articles, a total of 16 cases have been reported. 17 patients were lung adenocarcinoma, 2 patients did not describe whether to detect EGFR gene mutations, 1 patient did not have EGFR gene mutation; 10 patients were EGFR exon 19 deletion, 1 patient was ALK positive, 1 patient was EGFR exon 21L858R mutation, 2 patients were EGFR exon 20 insertion.
CONCLUSIONS: Lung adenocarcinoma with miliary metastasis in both lungs is a rare phenomenon. We should pay attention to the performance to avoid misdiagnosis. Most of the adenocarcinoma subtypes have EGFR mutations, and EGFR-tyrosine kinase inhibitors (EGFR-TKIs) are the preferred treatment choice for this type of patients.
Keywords: EGFR mutations; Lung adenocarcinoma; Lung miliary metastases; Lung neoplasms
References
- J Clin Oncol. 2009 Dec 20;27(36):6251-66 - PubMed
- Intensive Care Med. 2019 Oct;45(10):1472-1473 - PubMed
- N Engl J Med. 2018 Nov 15;379(20):1945 - PubMed
- Am J Med Sci. 2015 Apr;349(4):e4 - PubMed
- J Thorac Oncol. 2011 Jan;6(1):199-202 - PubMed
- Cureus. 2018 Oct 31;10(10):e3533 - PubMed
- Cancer. 2011 Feb 15;117(4):819-25 - PubMed
- Chest. 1993 Sep;104(3):948-50 - PubMed
- Acta Oncol. 2017 Sep;56(9):1175-1180 - PubMed
- CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17 - PubMed
- Thorac Cancer. 2015 Sep;6(5):629-35 - PubMed
- Clin Lung Cancer. 2014 Sep;15(5):387-9 - PubMed
- J Thorac Oncol. 2018 Jun;13(6):e95-e97 - PubMed
- Eur J Radiol. 2019 Dec 10;123:108780 - PubMed
- HSS J. 2017 Jul;13(2):201-206 - PubMed
- Eur Respir J. 2013 Feb;41(2):417-24 - PubMed
- Case Rep Oncol. 2014 Nov 19;7(3):769-73 - PubMed
- J Thorac Oncol. 2015 Sep;10(9):1375 - PubMed
- Ann Thorac Surg. 2019 Jul;108(1):e47 - PubMed
- Mol Clin Oncol. 2018 Dec;9(6):673-676 - PubMed
MeSH terms
Publication Types